Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Biofrontier Partners

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 10
Average round size
info
The average size of a deal this fund participated in
$25M
Portfolio companies 6
Rounds per year 0.45
Lead investments 0
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.40
Exits 5
Key employees Soon
Stages of investment
Late Stage Venture

Areas of investment

  • Biotechnology
  • Health Care
  • Genetics
  • Pharmaceutical
  • Medical
Summary

In 2001 was created Biofrontier Partners, which is appeared as VC. The main department of described VC is located in the San Diego. The company was established in North America in United States.

The usual cause for the fund is to invest in rounds with 5-6 partakers. Despite the Biofrontier Partners, startups are often financed by Zero Stage Capital, Versant Ventures, Sofinnova Investments. The meaningful sponsors for the fund in investment in the same round are Zero Stage Capital, Sanderling Ventures, Catalyst Health Ventures. In the next rounds fund is usually obtained by Zesiger Capital, Unilever Ventures, Sano Ventures.

The fund is generally included in less than 2 deals every year. The important activity for fund was in 2003. Comparing to the other companies, this Biofrontier Partners performs on 15 percentage points more the average number of lead investments. The usual things for fund are deals in the range of 10 - 50 millions dollars. The higher amount of exits for fund were in 2012.

Among the most popular portfolio startups of the fund, we may highlight Perlegen Sciences, BioTrove, CardioNet. We can highlight the next thriving fund investment areas, such as Therapeutics, Pharmaceutical. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. The fund has no exact preference in some founders of portfolio startups.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Biofrontier Partners:
Typical Co-investors
Biofrontier Partners is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Biofrontier Partners:

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Alchemy Partners England, London, United Kingdom
Argenthal Aix-en-Provence, France, Provence-Alpes-Côte d'Azur
BackingMinds -
Bioclub China, Hangzhou, Zhejiang
Blue Shield of California California, San Francisco, United States
Central Wisconsin Angel Investors Madison, United States, Wisconsin
Firelake Capital Management California, Palo Alto, United States
Good Ventures California, San Francisco, United States
MyBey Ventures -
Oaktree Specialty Lending Corp. New York, United States, White Plains
PLG Ventures California, Santa Monica, United States
R/GA New York, New York, United States
SEA Social Venture Fund Chiyoda, Japan
Simplex Japan, Tokyo
SINOCHEM GROUP Beijing, Beijing, China
Taiwan Development Fund -
Valneva France, Pays de la Loire, Saint-herblain
Vidici Ventures Stockholm, Stockholm County, Sweden
Xiangshui Dongting Ziben China, Hunan, Liuyang

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

BioTrove

Biotechnology
Genetics
Health Care
Life Science
$5M16 Jul 2005 Woburn, Massachusetts, United States

BioTrove

Biotechnology
Genetics
Health Care
Life Science
$10M29 Jan 2004 Woburn, Massachusetts, United States

CellZome

Biotechnology
Medical
Pharmaceutical
Therapeutics
$35M17 Mar 2003 Heidelberg, Baden-Württemberg, Germany

Perlegen Sciences

Biotechnology
Genetics
Health Care
Pharmaceutical
$30M28 Jan 2003 Mountain View, California, United States

CardioNet

Biotechnology
Health Care
Medical Device
$13M13 Jan 2003 Pennsylvania, United States

AnGes

Biopharma
Biotechnology
Genetics
Health Care
25 Sep 2002 Chiyoda, Japan

Salmedix Inc

Biotechnology
Health Care
Medical
$27M19 Jun 2002 San Diego, California, United States

CardioNet

Biotechnology
Health Care
Medical Device
$6M01 May 2000 Pennsylvania, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Biofrontier Partners?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 10
Average round size 25M
Rounds per year 0.45
Peak activity year 2003
Lead investments 0
Follow on index 0.40
Exits 5
Group Appearance index 0.90

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

BioTrove

Biotechnology
Genetics
Health Care
Life Science
$5M16 Jul 2005 Woburn, Massachusetts, United States

BioTrove

Biotechnology
Genetics
Health Care
Life Science
$10M29 Jan 2004 Woburn, Massachusetts, United States

CellZome

Biotechnology
Medical
Pharmaceutical
Therapeutics
$35M17 Mar 2003 Heidelberg, Baden-Württemberg, Germany

Perlegen Sciences

Biotechnology
Genetics
Health Care
Pharmaceutical
$30M28 Jan 2003 Mountain View, California, United States

CardioNet

Biotechnology
Health Care
Medical Device
$13M13 Jan 2003 Pennsylvania, United States

AnGes

Biopharma
Biotechnology
Genetics
Health Care
25 Sep 2002 Chiyoda, Japan

Salmedix Inc

Biotechnology
Health Care
Medical
$27M19 Jun 2002 San Diego, California, United States

CardioNet

Biotechnology
Health Care
Medical Device
$6M01 May 2000 Pennsylvania, United States
Crunchbase icon

Content report

The following text will be sent to our editors: